Recently by Leslie Gladstone Restaino
BioPharma Collaborative Agreements: Choosing The Right Deal Structure
Fierce competition in the pharmaceutical industry has changed the deal game. As always, companies are racing for the title of first to market with new products, first to achieve maximum market penetration, and the first to create barriers to competition. However, declining R&D productivity,...
Read MoreKnowledge Is Power: Commercializing Intellectual Property In The Life Sciences Industry
The explosion of life sciences-based innovations and increased globalization of the marketplace has heightened the importance of intellectual property ("IP") in business transactions. Effective management of IP is the driving force behind intellectual and commercial success for global life sciences...
Read More